EGCG induces lung cancer A549 cell apoptosis by regulating Ku70 acetylation

Oncology Reports

Volumn 35, Issue 4, 2016, Pages 2339-2347

  Li, Min ^a   Li, Jing Jing ^a   Gu, Qi Hua ^a   An, Jian ^a   Cao, Li Ming ^a   Yang, Hua Ping ^a   Hu, Cheng Ping ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

A549; Apoptosis; Bax, Epigallocatechin 3 gallate; Ku70 acetylation; Lung cancer; Tea

Indexed keywords

CASPASE 3; EPIGALLOCATECHIN GALLATE; KU ANTIGEN; PROTEIN BAX; PROTEIN BCL XL; ANTINEOPLASTIC AGENT; BAX PROTEIN, HUMAN; BCL2L1 PROTEIN, HUMAN; CASP3 PROTEIN, HUMAN; CATECHIN; PROTEIN BCL X;

A549 CELL LINE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ACETYLATION; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REGULATORY MECHANISM; STAINING; UPREGULATION; WESTERN BLOTTING; A-549 CELL LINE; ACETYLATION; ANALOGS AND DERIVATIVES; CELL SURVIVAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; LUNG NEOPLASMS; METABOLISM;

A549 CELLS; ACETYLATION; ANTICARCINOGENIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CASPASE 3; CATECHIN; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KU AUTOANTIGEN; LUNG NEOPLASMS;

EID: 84959269644     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2016.4587     Document Type: Article

References (30)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Kushi LH, Doyle C, McCullough M, Rock CL, Demark-Wahnefried W, Bandera EV, Gapstur S, Patel AV, Andrews K and Gansler T; American Cancer Society 2010 Nutrition and Physical Activity Guidelines Advisory Committee: American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 62: 30-67, 2012.
3. Jin L, Li C, Xu Y, Wang L, Liu J, Wang D, Hong C, Jiang Z, Ma Y, Chen Q, et al: Epigallocatechin gallate promotes p53 accumulation and activity via the inhibition of MDM2-mediated p53 ubiquitination in human lung cancer cells. Oncol Rep 29: 1983-1990, 2013.
4. Ma YC, Li C, Gao F, Xu Y, Jiang ZB, Liu JX and Jin LY: Epigallocatechin gallate inhibits the growth of human lung cancer by directly targeting the EGFR signaling pathway. Oncol Rep 31: 1343-1349, 2014.
5. Lee YH, Kwak J, Choi HK, Choi KC, Kim S, Lee J, Jun W, Park HJ and Yoon HG: EGCG suppresses prostate cancer cell growth modulating acetylation of androgen receptor by antihistone acetyltransferase activity. Int J Mol Med 30: 69-74, 2012.
6. Tang Y, Zhao DY, Elliott S, Zhao W, Curiel TJ, Beckman BS and Burow ME: Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression. Int J Oncol 31: 705-711, 2007.
7. Yang CS and Wang ZY: Tea and cancer. J Natl Cancer Inst 85: 1038-1049, 1993.
8. Wu H, Xin Y, Xiao Y and Zhao J: Low-dose docetaxel combined with epigallocatechin-3-gallate inhibits angiogenesis and tumor growth in nude mice with gastric cancer xenografts. Cancer Biother Radiopharm 27: 204-209, 2012.
9. Zhang G, Wang Y, Zhang Y, Wan X, Li J, Liu K, Wang F, Liu K, Liu Q, Yang C, et al: Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy. Curr Mol Med 12: 163-176, 2012.
10. Tudoran O, Soritau O, Balacescu O, Balacescu L, Braicu C, Rus M, Gherman C, Virag P, Irimie F and Berindan-Neagoe I: Early transcriptional pattern of angiogenesis induced by EGCG treatment in cervical tumour cells. J Cell Mol Med 16: 520-530, 2012.
11. Lu YP, Lou YR, Xie JG, Peng QY, Liao J, Yang CS, Huang MT and Conney AH: Topical applications of caffeine or epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proc Natl Acad Sci USA 99: 12455-12460, 2002.
12. Syed DN, Afaq F, Kweon MH, Hadi N, Bhatia N, Spiegelman VS and Mukhtar H: Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-kappaB activation in normal human bronchial epithelial cells. Oncogene 26: 673-682, 2007.
13. Lee MH, Han DW, Hyon SH and Park JC: Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-?B. Apoptosis 16: 75-85, 2011.
14. Tsukamoto S, Hirotsu K, Kumazoe M, Goto Y, Sugihara K, Suda T, Tsurudome Y, Suzuki T, Yamashita S, Kim Y, et al: Green tea polyphenol EGCG induces lipid-raft clustering and apoptotic cell death by activating protein kinase C? and acid sphingomyelinase through a 67 kDa laminin receptor in multiple myeloma cells. Biochem J 443: 525-534, 2012.
15. Adachi S, Nagao T, Ingolfsson HI, Maxfield FR, Andersen OS, Kopelovich L and Weinstein IB: The inhibitory effect of epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells. Cancer Res 67: 6493-6501, 2007.
16. Wei LH, Kuo ML, Chen CA, Chou CH, Lai KB, Lee CN and Hsieh CY: Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene 22: 1517-1527, 2003.
17. Wang X, Hao MW, Dong K, Lin F, Ren JH and Zhang HZ: Apoptosis induction effects of EGCG in laryngeal squamous cell carcinoma cells through telomerase repression. Arch Pharm Res 32: 1263-1269, 2009.
18. Wang J, Xie Y, Feng Y, Zhang L, Huang X, Shen X and Luo X: Epigallocatechingallate induces apoptosis in B lymphoma cells via caspase-dependent pathway and Bcl-2 family protein modulation. Int J Oncol 46: 1507-1515, 2015.
19. Sonoda JI, Ikeda R, Baba Y, Narumi K, Kawachi A, Tomishige E, Nishihara K, Takeda Y, Yamada K, Sato K, et al: Green tea catechin, epigallocatechin-3-gallate, attenuates the cell viability of human non-small-cell lung cancer A549 cells via reducing Bcl-xL expression. Exp Ther Med 8: 59-63, 2014.
20. Hurwitz JL, Stasik I, Kerr EM, Holohan C, Redmond KM, McLaughlin KM, Busacca S, Barbone D, Broaddus VC, Gray SG, et al: Vorinostat/SAHA-induced apoptosis in malignant mesothelioma is FLIP/caspase 8-dependent and HR23B-independent. Eur J Cancer 48: 1096-1107, 2012.
21. Hada M and Kwok RP: Regulation of ku70-bax complex in cells. J Cell Death 7: 11-13, 2014.
22. Li JJ, Gu QH, Li M, Yang HP, Cao LM and Hu CP: Role of Ku70 and Bax in epigallocatechin-3-gallate-induced apoptosis of A549 cells in vivo. Oncol Lett 5: 101-106, 2013.
23. Kang HG, Jenabi JM, Liu XF, Reynolds CP, Triche TJ and Sorensen PH: Inhibition of the insulin-like growth factor I receptor by epigallocatechin gallate blocks proliferation and induces the death of Ewing tumor cells. Mol Cancer Ther 9: 1396-1407, 2010.
24. Wu PP, Kuo SC, Huang WW, Yang JS, Lai KC, Chen HJ, Lin KL, Chiu YJ, Huang LJ and Chung JG: Epigallocatechin gallate induced apoptosis in human adrenal cancer NCI-H295 cells through caspase-dependent and caspase-independent pathway. Anticancer Res 29: 1435-1442, 2009.
25. Deveraux QL, Schendel SL and Reed JC: Antiapoptotic proteins. The bcl-2 and inhibitor of apoptosis protein families. Cardiol Clin 19: 57-74, 2001.
26. Gu Q, Hu C, Chen Q and Xia Y: Tea polyphenols prevent lung from preneoplastic lesions and effect p53 and bcl-2 gene expression in rat lung tissues. Int J Clin Exp Pathol 6: 1523-1531, 2013.
27. Hastak K, Agarwal MK, Mukhtar H and Agarwal ML: Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate. FASEB J 19: 789-791, 2005.
28. Sawada M, Sun W, Hayes P, Leskov K, Boothman DA and Matsuyama S: Ku70 suppresses the apoptotic translocation of Bax to mitochondria. Nat Cell Biol 5: 320-329, 2003.
29. Sawada M, Hayes P and Matsuyama S: Cytoprotective membrane-permeable peptides designed from the Bax-binDing domain of Ku70. Nat Cell Biol 5: 352-357, 2003.
30. Cohen HY, Lavu S, Bitterman KJ, Hekking B, Imahiyerobo TA, Miller C, Frye R, Ploegh H, Kessler BM and Sinclair DA: Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. Mol Cell 13: 627-638, 2004.